Cục Thông tin KH&CN Quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 11/06 đến ngày 18/06/2021.
SCIENCEDIRECT
1. In silico detection of inhibitor potential of Passiflora compounds against SARS-Cov-2(Covid-19) main protease by using molecular docking and dynamic analyses
Journal of Molecular Structure, 4 May 2021, Volume 1240, Article 130556
Serap Yalçın, Seda Yalçınkaya, Fahriye Ercan
2. Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients
International Immunopharmacology, 9 December 2020, Volume 90, Article 107271
Yanan Wang, Jingjing Li, Chunguang Yang
3. Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals
Diagnostic Microbiology and Infectious Disease, 20 November 2020, Volume 99, Issue 3, Article 115273
Haleema Ali Alserehi, Ada Mohammed Alqunaibet, Ahmed Mohammed Albarrag
4. Structural insights and inhibition mechanism of TMPRSS2 by experimentally known inhibitors Camostat mesylate, Nafamostat and Bromhexine hydrochloride to control SARS-coronavirus-2: A molecular modeling approach
Informatics in Medicine Unlocked, 26 May 2021, Volume 24, Article 100597
Kailas D. Sonawane, Sagar S. Barale, Vikramsinh B. More
5. Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China
Journal of Virus Eradication, 8 May 2021, Volume 7, Issue 2, Article 100040
Xiangsha Kong, Feng Liu, Hongsong Chen
6. Lung organoid simulations for modelling and predicting the effect of mutations on SARS-CoV-2 infectivity
Computational and Structural Biotechnology Journa, l26 March 2021, Volume 19, Pages 1701-1712
Sally Esmail, Wayne R. Danter
7. Molecular basis of the new COVID-19 target neuropilin-1 in complex with SARS-CoV-2 S1 C-end rule peptide and small-molecule antagonists
Journal of Molecular Liquids, 20 May 2021, Volume 335, Article 116537
Methus Klaewkla, Thanapon Charoenwongpaiboon, Panupong Mahalapbutr
8. Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection
Molecular Therapy - Methods & Clinical Development, 14 May 2021, Volume 21, Pages 754-764
Xiaoqing Zhang, Ping Han, Xuanming Yang
9. Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution
EBioMedicine, 7 March 2021, Volume 65, Article 103262
Eugenia Z Ong, Shirin Kalimuddin, Kuan Rong Chan
10. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19
International Immunopharmacology, 22 March 2021, Volume 95, Article 107568
Mohsen Ahmadi, Salar Pashangzadeh, Nima Rezaei
11. Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies
European Journal of Medicinal Chemistry, 30 May 2021, Volume 222, Article 113584
Wayne Vuong, Conrad Fischer, John C. Vederas
12. Phenoxazine nucleoside derivatives with a multiple activity against RNA and DNA viruses
European Journal of Medicinal Chemistry, 15 April 2021, Volume 220, Article 113467
Liubov I. Kozlovskaya, Viktor P. Volok, Andrey V. Aralov
13. Molecules against Covid-19: An in silico approach for drug development
Journal of Electronic Science and Technology, 11 March 2021, Volume 19, Issue 1, Article 100095
Rhythm Bharti, Sandeep Kumar Shukla
14. Probing nano-QSAR to assess the interactions between carbon nanoparticles and a SARS-CoV-2 RNA fragment
Ecotoxicology and Environmental Safety, 19 May 2021, Volume 219,Article 112357
Fan Zhang, Zhuang Wang, Willie J. G. M. Peijnenburg
15. Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro
Microbial Pathogenesis, 29 April 2021, Volume 156, Article 104929
Xiangjun Wang, Jiayu Lu, Huaizhen He
16. Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2
Infection, Genetics and Evolution, 15 May 2021, Volume 93, Article 104923
Mengmei Yang, Mengdi Qi, Yunzhang Hu
17. Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response
Stem Cell Reports, 13 April 2021, Volume 16, Issue 4, Pages 940-953
Aditya Mithal, Adam J. Hume, Gustavo Mostoslavsky
18. Efficacy and validity of automated quantitative chemiluminescent enzyme immunoassay for SARS-CoV-2 antigen test from saliva specimen in the diagnosis of COVID-19
Journal of Infection and Chemotherapy, 2 April 2021, Volume 27, Issue 7, Pages 1039-1042
Nobuhiro Asai, Daisuke Sakanashi, Hiroshige Mikamo
WILEY:
1. Severe loss of mechanical efficiency in COVID-19 patients
Eulogio Pleguezuelos, Amin Del Carmen, Gemma Llorensi, Jessica Carcole, Paula Casarramona, Eva Moreno, Pilar Ortega, Mateo Serra-Prat, Elisabet Palomera, Marc M. Miravitlles, Joan Carles Yebenes, Ramón Boixeda, Lluis Campins, Koldo Villelabeitia-Jaureguizar, Manuel Vicente Garnacho-Castaño
Journal of Cachexia, Sarcopenia and Muscle
First published: 08 June 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcsm.12739
2. Vertical transmission of SARS-CoV2 during pregnancy: A high-risk cohort
Mariane de Fátima Yukie Maeda, Maria de Lourdes Brizot, Maria Augusta B. C. Gibelli, Silvia Maria Ibidi, Werther Brunow de Carvalho, Mara Sandra Hoshida, Clarisse Martins Machado, Ester Cerdeira Sabino, Lea Campos de Oliveira da Silva, Thomas Jaenisch, Maria Cassia Mendes-Correa, Philippe Mayaud,
Prenatal Diagnosis
First published: 08 June 2021
https://obgyn.onlinelibrary.wiley.com/doi/epdf/10.1002/pd.5980
3. Umbilical cord mesenchymal stromal cells as critical COVID‐19 adjuvant therapy: A randomized controlled trial
Ismail Hadisoebroto Dilogo, Dita Aditianingsih, Adhrie Sugiarto, Erlina Burhan, Triya Damayanti, Pompini Agustina Sitompul, Nina Mariana, Radiana D. Antarianto, Isabella Kurnia Liem, Tera Kispa, Fajar Mujadid, Novialdi Novialdi, Evah Luviah, Tri Kurniawati, Andri M. T. Lubis, Dina Rahmatika
STEM CELLS Translational Medicine
First published: 08 June 2021
https://stemcellsjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/sctm.21-0046
4. Prevalence of IgG antibodies induced by the sars-cov-2 virus in asymptomatic adults in nuevo, mexico.
Edgar P. Rodríguez-Vidales, Denise Garza-Carrillo, José J. Pérez-Trujillo, Olivia A. Robles-Rodríguez, Ana María Salinas-Martínez, Roberto Montes de Oca-Luna, Consuelo Treviño-Garza, Manuel E. de la O-Cavazos
Journal of Medical Virology
First published: 07 June 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27131
5. Management of a patient with a rare congenital limb malformation syndrome after SARS‐CoV‐2 vaccine‐induced thrombosis and thrombocytopenia (VITT)
Sandheeah Ramdeny, Ailidh Lang, Sara Al-Izzi, Alexander Hung, Imran Anwar, Poornima Kumar
British Journal of Haematology
First published: 07 June 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjh.17619
SPRINGER NATURE
1. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients
Jira Chansaenroj, Ritthideach Yorsaeng, Nawarat Posuwan… in Virology Journal (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12985-021-01530-2.pdf
2. Extrapulmonary features of post-COVID-19 patients: muscle function, physical activity, mood, and sleep quality
Aylin Tanriverdi, Sema Savci… in Irish Journal of Medical Science (1971 -) (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11845-021-02667-3.pdf
3. Focus on renal blood flow in mechanically ventilated patients with SARS-CoV-2: a prospective pilot study
Alberto Fogagnolo, Salvatore Grasso… in Journal of Clinical Monitoring and Computi… (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10877-020-00633-5.pdf
4. Can a modified-simplified pulmonary embolism severity index (m-sPESI) be used to predict the need for intensive care in hospitalized COVID-19 patients?
Ahmet Kagan As, Burak Erdolu, Burak Duman… in Journal of Thrombosis and Thrombolysis (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11239-021-02405-7.pdf
5. Prevalence of liver injury in 445 patients with Corona Virus Disease-19-Single-centre experience from southern India
Hemamala V. Saithanyamurthi, Manoj Munirathinam… in Indian Journal of Gastroenterology (2021)
https://link.springer.com/content/pdf/10.1007%2Fs12664-021-01147-x.pdf
6. Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Si-Hyuck Kang, Dong-Hoon Lee, Kyung-Do Han, Jin-Hyung Jung… in Clinical Hypertension (2021)
https://link.springer.com/content/pdf/10.1186%2Fs40885-021-00168-0.pdf
7. CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients
Ramazan Gunduz, Bekir Serhat Yildiz… in Journal of Thrombosis and Thrombolysis (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11239-021-02427-1.pdf
8. Pattern of genomic variation in SARS-CoV-2 (COVID-19) suggests restricted nonrandom changes: Analysis using Shewhart control charts
SAURAV MANDAL, TANMOY ROYCHOWDHURY, ALOK BHATTACHARYA in Journal of Biosciences (2021)
https://link.springer.com/content/pdf/10.1007%2Fs12038-020-00131-5.pdf